These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38320632)

  • 1. Periostin in Cancer-Associated Fibroblasts Promotes Esophageal Squamous Cell Carcinoma Progression by Enhancing Cancer and Stromal Cell Migration.
    Miyako S; Koma YI; Nakanishi T; Tsukamoto S; Yamanaka K; Ishihara N; Azumi Y; Urakami S; Shimizu M; Kodama T; Nishio M; Shigeoka M; Kakeji Y; Yokozaki H
    Am J Pathol; 2024 May; 194(5):828-848. PubMed ID: 38320632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urokinase plasminogen activator secreted by cancer-associated fibroblasts induces tumor progression via PI3K/AKT and ERK signaling in esophageal squamous cell carcinoma.
    Tian B; Chen X; Zhang H; Li X; Wang J; Han W; Zhang LY; Fu L; Li Y; Nie C; Zhao Y; Tan X; Wang H; Guan XY; Hong A
    Oncotarget; 2017 Jun; 8(26):42300-42313. PubMed ID: 28404945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibroblast activation protein-positive fibroblasts promote tumor progression through secretion of CCL2 and interleukin-6 in esophageal squamous cell carcinoma.
    Higashino N; Koma YI; Hosono M; Takase N; Okamoto M; Kodaira H; Nishio M; Shigeoka M; Kakeji Y; Yokozaki H
    Lab Invest; 2019 Jun; 99(6):777-792. PubMed ID: 30683902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Periostin derived from cancer-associated fibroblasts promotes esophageal squamous cell carcinoma progression via ADAM17 activation.
    Ishibashi Y; Mochizuki S; Horiuchi K; Tsujimoto H; Kouzu K; Kishi Y; Okada Y; Ueno H
    Biochim Biophys Acta Mol Basis Dis; 2023 Jun; 1869(5):166669. PubMed ID: 36813090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PAI-1 derived from cancer-associated fibroblasts in esophageal squamous cell carcinoma promotes the invasion of cancer cells and the migration of macrophages.
    Sakamoto H; Koma YI; Higashino N; Kodama T; Tanigawa K; Shimizu M; Fujikawa M; Nishio M; Shigeoka M; Kakeji Y; Yokozaki H
    Lab Invest; 2021 Mar; 101(3):353-368. PubMed ID: 33311557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Periostin promotes ovarian cancer metastasis by enhancing M2 macrophages and cancer-associated fibroblasts via integrin-mediated NF-κB and TGF-β2 signaling.
    Lin SC; Liao YC; Chen PM; Yang YY; Wang YH; Tung SL; Chuang CM; Sung YW; Jang TH; Chuang SE; Wang LH
    J Biomed Sci; 2022 Dec; 29(1):109. PubMed ID: 36550569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIC-5 in cancer-associated fibroblasts contributes to esophageal squamous cell carcinoma progression.
    Du X; Xu Q; Pan D; Xu D; Niu B; Hong W; Zhang R; Li X; Chen S
    Cell Death Dis; 2019 Nov; 10(12):873. PubMed ID: 31740661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stromal POSTN induced by TGF-β1 facilitates the migration and invasion of ovarian cancer.
    Yue H; Li W; Chen R; Wang J; Lu X; Li J
    Gynecol Oncol; 2021 Feb; 160(2):530-538. PubMed ID: 33317907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of miR-100-5p in cancer-associated fibroblast-derived exosomes facilitates lymphangiogenesis in esophageal squamous cell carcinoma.
    Chen C; Yang C; Tian X; Liang Y; Wang S; Wang X; Shou Y; Li H; Xiao Q; Shu J; Sun M; Chen K
    Cancer Med; 2023 Jul; 12(13):14468-14483. PubMed ID: 37184125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Periostin secreted by cancer-associated fibroblasts promotes cancer progression and drug resistance in non-small cell lung cancer.
    Takatsu F; Suzawa K; Tomida S; Thu YM; Sakaguchi M; Toji T; Ohki M; Tsudaka S; Date K; Matsuda N; Iwata K; Zhu Y; Nakata K; Shien K; Yamamoto H; Nakayama A; Okazaki M; Sugimoto S; Toyooka S
    J Mol Med (Berl); 2023 Dec; 101(12):1603-1614. PubMed ID: 37831111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CCL3-CCR5 axis contributes to progression of esophageal squamous cell carcinoma by promoting cell migration and invasion via Akt and ERK pathways.
    Kodama T; Koma YI; Arai N; Kido A; Urakawa N; Nishio M; Shigeoka M; Yokozaki H
    Lab Invest; 2020 Sep; 100(9):1140-1157. PubMed ID: 32457351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer-associated fibroblasts-derived exosomal miR-3656 promotes the development and progression of esophageal squamous cell carcinoma via the ACAP2/PI3K-AKT signaling pathway.
    Jin Y; Meng Q; Zhang B; Xie C; Chen X; Tian B; Wang J; Shih TC; Zhang Y; Cao J; Yang Y; Chen S; Guan X; Chen X; Hong A
    Int J Biol Sci; 2021; 17(14):3689-3701. PubMed ID: 34671193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. S100A8/A9 Induced by Interaction with Macrophages in Esophageal Squamous Cell Carcinoma Promotes the Migration and Invasion of Cancer Cells via Akt and p38 MAPK Pathways.
    Tanigawa K; Tsukamoto S; Koma YI; Kitamura Y; Urakami S; Shimizu M; Fujikawa M; Kodama T; Nishio M; Shigeoka M; Kakeji Y; Yokozaki H
    Am J Pathol; 2022 Mar; 192(3):536-552. PubMed ID: 34954212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer-associated fibroblast-derived periostin promotes papillary thyroid tumor growth through integrin-FAK-STAT3 signaling.
    Jin X; Deng Q; Ye S; Liu S; Fu Y; Liu Y; Wu G; Ouyang G; Wu T
    Theranostics; 2024; 14(7):3014-3028. PubMed ID: 38773979
    [No Abstract]   [Full Text] [Related]  

  • 15. Metallothionein 2A Expression in Cancer-Associated Fibroblasts and Cancer Cells Promotes Esophageal Squamous Cell Carcinoma Progression.
    Shimizu M; Koma YI; Sakamoto H; Tsukamoto S; Kitamura Y; Urakami S; Tanigawa K; Kodama T; Higashino N; Nishio M; Shigeoka M; Kakeji Y; Yokozaki H
    Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CAF-secreted CXCL1 conferred radioresistance by regulating DNA damage response in a ROS-dependent manner in esophageal squamous cell carcinoma.
    Zhang H; Yue J; Jiang Z; Zhou R; Xie R; Xu Y; Wu S
    Cell Death Dis; 2017 May; 8(5):e2790. PubMed ID: 28518141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemokine (C-C Motif) Ligand 1 Derived from Tumor-Associated Macrophages Contributes to Esophageal Squamous Cell Carcinoma Progression via CCR8-Mediated Akt/Proline-Rich Akt Substrate of 40 kDa/Mammalian Target of Rapamycin Pathway.
    Fujikawa M; Koma YI; Hosono M; Urakawa N; Tanigawa K; Shimizu M; Kodama T; Sakamoto H; Nishio M; Shigeoka M; Kakeji Y; Yokozaki H
    Am J Pathol; 2021 Apr; 191(4):686-703. PubMed ID: 33460563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting MFGE8 secreted by cancer-associated fibroblasts blocks angiogenesis and metastasis in esophageal squamous cell carcinoma.
    Liu B; Zhang B; Qi J; Zhou H; Tan L; Huang J; Huang J; Fang X; Gong L; Luo J; Liu S; Fu L; Ling F; Ma S; Lai-Wan Kwong D; Wang X; Guan XY
    Proc Natl Acad Sci U S A; 2023 Oct; 120(42):e2307914120. PubMed ID: 37816055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NCAM- and FGF-2-mediated FGFR1 signaling in the tumor microenvironment of esophageal cancer regulates the survival and migration of tumor-associated macrophages and cancer cells.
    Takase N; Koma Y; Urakawa N; Nishio M; Arai N; Akiyama H; Shigeoka M; Kakeji Y; Yokozaki H
    Cancer Lett; 2016 Sep; 380(1):47-58. PubMed ID: 27317650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic significance of cancer-associated fibroblasts in esophageal squamous cell carcinoma.
    Ha SY; Yeo SY; Xuan YH; Kim SH
    PLoS One; 2014; 9(6):e99955. PubMed ID: 24945657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.